Intelligence · Clinical pipeline
Approved programs Pipeline Programs
ClinicalTrials.gov programs marked approved or launched in registry data.
Quick answer
NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.
Top sponsors
- Chinese Academy of 207 programs
- First People's Hospital 186 programs
- Takeda 154 programs
- United Therapeutics Europe 121 programs
- BRIGHT MINDS BIOSCIENCES 116 programs
- Disc Medicine 103 programs
- George Institute for 83 programs
- Hospital Authority 60 programs
- Regeneron UK 60 programs
- Sinovac Research and 47 programs
- Teva Pharma 39 programs
- Pacira Ireland 36 programs
Pipeline programs
-
Bacillus Clausii Multi ATB Resist
Sanofi Pasteur
Diarrhea, Infantile
1 trial -
Baricitinib 4 MG
Chinese University of Hong Kong
Rheumatoid Arthritis
1 trial -
Basiliximab
The First People's Hospital of Lianyungang
Safety and Efficacy
1 trial -
Basiliximab,
The First People's Hospital of Lianyungang
Beta-Thalassemia Major
1 trial -
Bavencio 20 mg/mL concentrate for solution for infusion
Disc Medicine
urothelial cancer, Bladder cancer, muscle invasive bladder cancer
1 trial -
Beclomethasone (QVAR)
Teva Pharma GmbH
Asthma
1 trial -
Behavior Therapy
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Use Disorder
2 trials -
Behavioral Intervention
BRIGHT MINDS BIOSCIENCES INC.
Cannabis Dependence
1 trial -
Behavioral: Buprenorphine/naloxone maintenance (Mtn)
BRIGHT MINDS BIOSCIENCES INC.
Opiate Dependence
1 trial -
Bempedoic Acid / Ezetimibe Oral Tablet
Esperion Therapeutics
Cardiovascular Diseases
1 trial -
Bempedoic Acid 180 MG Oral Tablet
Esperion Therapeutics
Healthy Lactating Women
1 trial -
Benlysta 200 mg solution for injection in pre-filled pen.
GlaxoSmithKline
Systemic Lupus Erythematosus
1 trial -
Berberine
The First People's Hospital of Lianyungang
Diabetes Mellitus
1 trial -
Berberine plus lifestyle intervention
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Obesity
1 trial -
Bevacizumab
Arrowhead Pharmaceuticals Ireland Limited
Pterygium
1 trial -
Biktarvy 50 mg/200 mg/25 mg film-coated tablets
Gilead Sciences Pty Limited
HIV-1 infection
1 trial -
Bilaxten Flas 10 mg comprimidos bucodispersables
A. Menarini Industrie Farmaceutiche Riunite s.r.l.
Allergic rhinoconjunctivitis
1 trial -
Bimatoprost
Cardiff Oncology
Graves' Ophthalmopathy
1 trial -
BioPhenoT2D
Fondazione Telethon ETS
type 2 diabetes
1 trial -
Biomarker
United Therapeutics Europe Ltd
Transplantation, Liver
1 trial -
Bismuth-based susceptibility-guided treatment
Hospital Authority, Hong Kong
Helicobacter Pylori
1 trial -
Bisoprolol
Merck KGaA, Darmstadt, Germany
Hypertension
1 trial -
Bisoprolol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypertension
1 trial -
Bleomycin
BRIGHT MINDS BIOSCIENCES INC.
Keloid
1 trial -
Blinatumomab
The First People's Hospital of Lianyungang
Acute B-cell Lymphoblastic Leukemia
1 trial -
Blood Glucose Meter Systems
Universal Integrated
Diabetes
1 trial -
Bortezomib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Waldenström Macroglobulinemia
1 trial -
Botulinum Toxin A
United Therapeutics Europe Ltd
Low Back Pain
1 trial -
Botulinum Toxin Type B
SUPERNUS PHARMACEUTICALS, INC.
Cervical Dystonia
1 trial -
Brand lamotrigine
BRIGHT MINDS BIOSCIENCES INC.
Epilepsy
1 trial -
Breeze2 glucometer
Hospital Authority, Hong Kong
Diabetes
1 trial -
Brentuximab vedotin
Takeda
Lymphoma
2 trials -
Brentuximab vedotin
Takeda
T-Cell Lymphoma
1 trial -
Brivudine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Herpes Zoster
1 trial -
Brixadi (Injectable Buprenorphine)
BRIGHT MINDS BIOSCIENCES INC.
Opioid Use Disorder
1 trial -
Brolucizumab
The University of Hong Kong
Age-Related Macular Degeneration
1 trial -
Brucea javanica oil emulsion injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colorectal Cancer
1 trial -
Bubble-Enhanced FAST (BEFAST)
United Therapeutics Europe Ltd
Abdominal Trauma
1 trial -
Buccal Buprenorphine 300 mcg
BRIGHT MINDS BIOSCIENCES INC.
Analgesia
1 trial -
Budesonide 200 microgram/Puff, HFA MDI
The First People's Hospital of Lianyungang
Asthma
1 trial -
Budesonide-Surfactant
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Premature Infants
1 trial -
Bupivacaine
Hospital Authority, Hong Kong
Pain
1 trial -
Bupivacaine
United Therapeutics Europe Ltd
Amputation Stumps
1 trial -
Bupivacaine FNB
Pacira Ireland Limited
Pain
1 trial -
Bupivacaine HCl
Heron Therapeutics
Analgesia
1 trial -
Bupivacaine Hydrochloride
The First People's Hospital of Lianyungang
Pulmonary Nodule
1 trial -
Bupivacaine Hydrochloride
Heron Therapeutics
Analgesia
1 trial -
Bupivacaine Injection [Marcaine]
The University of Hong Kong
Acute Pain
1 trial
Frequently asked questions
How many Approved programs pipeline programs are in the directory?
1,839 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.